Showing 661-680 of 7110 for: Cochrane Systematic Reviews Back
- Anti-spasticity agents for multiple sclerosis
Cochrane Systematic Reviews, 17-Sep-2008
Spasticity is a common problem in multiple sclerosis (MS) patients causing pain, spasms, loss of function and difficulties in nursing care. A variety of oral and parenteral medications are available.
- Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants
Cochrane Systematic Reviews, 17-Feb-2009
Nosocomial infection is a major problem affecting the immediate health and long-term outcome of preterm and very low birth weight neonates. More than half of these infections are caused by staphylococci. Various type specific antibodies targeted at differ
- Antistreptococcal interventions for guttate and chronic plaque psoriasis
Cochrane Systematic Reviews, 5-Mar-2019
Psoriasis is a chronic skin disease that affects approximately two per cent of the general population. Plaque psoriasis is the most common form: it usually appears as raised, red patches of inflamed skin, covered with silvery white scales. The patches oft
- Antistreptococcal interventions for guttate and chronic plaque psoriasis
Cochrane Systematic Reviews, 12-Jan-2016
Guttate psoriasis is a distinctive acute form of psoriasis which characteristically occurs in children and young adults. It is closely associated with preceding streptococcal sore throat or tonsillitis. Some authorities have claimed that ordinary (chronic
- Antithrombin for respiratory distress syndrome in preterm infants
Cochrane Systematic Reviews, 24-Jan-2010
Acquired Antithrombin (AT) deficiency is a common and prognostically important finding in sick preterm infants with respiratory distress syndrome (RDS). It has been hypothesised that AT concentrate may improve clinical outcomes in preterm infants with RDS
- Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants
Cochrane Systematic Reviews, 21-Mar-2016
Preterm birth remains the major risk factor for the development of intraventricular hemorrhage, an injury that occurs in 25% of very low birth weight infants. Intraventricular hemorrhage is thought to be venous in origin and intrinsic thromboses in the ge
- Antithrombin III for critically ill patients
Cochrane Systematic Reviews, 11-Jan-2016
Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effect
- Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery
Cochrane Systematic Reviews, 21-Apr-2014
Peripheral arterial disease (PAD) is frequently treated by either an infrainguinal autologous (using the patient's own veins) or synthetic graft bypass. The rate of occlusion of the graft after one year is between 12% and 60%. To prevent occlusion, patien
- Antithrombotic drugs for carotid artery dissection
Cochrane Systematic Reviews, 6-Mar-2011
Extracranial internal carotid artery dissection (eICAD) is a leading cause of stroke in younger patients.
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
Cochrane Systematic Reviews, 28-Sep-2021
Multiple myeloma is a malignant plasma cell disorder characterised by clonal plasma cells that cause end-organ damage such as renal failure, lytic bone lesions, hypercalcaemia and/or anaemia. People with multiple myeloma are treated with immunomodulatory
- Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction
Cochrane Systematic Reviews, 17-Jul-2013
Pregnancy complications such as pre-eclampsia and eclampsia, intrauterine growth restriction and placental abruption are thought to have a common origin related to abnormalities in the development and function of the placenta.
- Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia
Cochrane Systematic Reviews, 13-Jul-2022
Cerebral small vessel disease is a progressive disease of the brain's deep perforating blood vessels. It is usually diagnosed based on lesions seen on brain imaging. Cerebral small vessel disease is a common cause of stroke but can also cause a progressiv
- Antithrombotic treatment after stroke due to intracerebral haemorrhage
Cochrane Systematic Reviews, 25-May-2017
Survivors of stroke due to intracerebral haemorrhage (ICH) are at risk of thromboembolism. Antithrombotic (antiplatelet or anticoagulant) treatments may lower the risk of thromboembolism after ICH, but they may increase the risks of bleeding.
- Antithyroid drug regimen for treating Graves' hyperthyroidism
Cochrane Systematic Reviews, 10-Nov-2009
Antithyroid drugs are widely used in the therapy of hyperthyroidism. There are wide variations in the dose, regimen or duration of treatment used by health professionals.
- Anti‐TNF agents for paediatric psoriasis
Cochrane Systematic Reviews, 24-Nov-2015
Psoriasis is a chronic skin disease that may develop at any age. Estimates for the United States and Europe suggest that psoriasis accounts for 4% of skin diseases in children. In most cases, the condition is mild and can be treated with creams. However,
- Anti-TNF-α treatment for pelvic pain associated with endometriosis
Cochrane Systematic Reviews, 27-Feb-2013
Endometriosis is a chronic, recurring condition that can develop during the reproductive years. It is characterised by the development of endometrial tissue outside the uterine cavity. It is the most common cause of pelvic pain in women. This endometrial
- Anti-tuberculous therapy for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 11-Feb-2015
There have been a number of studies with conflicting results which have examined the effect of anti-tuberculous therapy in Crohn's disease. A meta-analysis was performed to evaluate the use of anti-tuberculous therapy for the maintenance of remission in C
- Antitumour antibiotic containing regimens for metastatic breast cancer
Cochrane Systematic Reviews, 6-Aug-2008
Antitumour antibiotics are used in the management of metastatic breast cancer. Some of these agents have demonstrated higher tumour response rates than non-antitumour antibiotic regimens, however a survival benefit has not been established in this setting
- Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
Cochrane Systematic Reviews, 22-Feb-2016
Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis in fetal life. Recently, researchers have attempted to use anti-VEGF agents for the treatment of retinopathy of prematurity (ROP), a vasoproliferative disorder. There is currently
- Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery
Cochrane Systematic Reviews, 12-Jan-2016
Trabeculectomy is performed as a treatment for glaucoma to lower intraocular pressure (IOP). The surgical procedure involves creating a channel through the wall of the eye. However scarring during wound healing can block this channel which will lead to th
